For: | Hasunuma H, Shimizu N, Yokota H, Tatsuno I. Azacitidine decreases reactive oxygen species production in peripheral white blood cells: A case report. World J Clin Cases 2020; 8(22): 5657-5662 [PMID: 33344557 DOI: 10.12998/wjcc.v8.i22.5657] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i22/5657.htm |
Number | Citing Articles |
1 |
Xue-Mei Zheng, Zhuo Yang, Guang-Li Yang, Yan Huang, Jie-Ru Peng, Meng-Jun Wu. Lung injury after cardiopulmonary bypass: Alternative treatment prospects. World Journal of Clinical Cases 2022; 10(3): 753-761 doi: 10.12998/wjcc.v10.i3.753
|
2 |
Qiangan Jing, Chaoting Zhou, Junyu Zhang, Ping Zhang, Yunyi Wu, Junyu Zhou, Xiangmin Tong, Yanchun Li, Jing Du, Ying Wang. Role of reactive oxygen species in myelodysplastic syndromes. Cellular & Molecular Biology Letters 2024; 29(1) doi: 10.1186/s11658-024-00570-0
|
3 |
Paola Montes, Ana Guerra-Librero, Paloma García, María Elena Cornejo-Calvo, María del Señor López, Tomás de Haro, Laura Martínez-Ruiz, Germaine Escames, Darío Acuña-Castroviejo. Effect of 5-Azacitidine Treatment on Redox Status and Inflammatory Condition in MDS Patients. Antioxidants 2022; 11(1): 139 doi: 10.3390/antiox11010139
|